Fosinopril and Carvedilol Reverse Hypertrophy and Change the Levels of Protein Kinase Cɛ and Components of Its Signaling Complex

By He Hua   Wang Wen   Zhang Huimin   Ma Liyuan   Wu Haiying   Wang Peihe   Gao Jiuming  

Cardiovascular Drugs and Therapy, Vol. 21, Iss. 1, 2007-02 ,pp. : 73-74

Springer Publishing Company

Access to resources Recommend Favorite

Phosphoinositide-3 Kinase Signaling in Cardiac Hypertrophy and Heart Failure

By  

Current Pharmaceutical Design, Vol. 17, Iss. 18, 2011-06 ,pp. : 1818-1824

Bentham Science Publishers

Access to resources Recommend Favorite

Carvedilol inhibits activation of stress-activated protein kinase and reduces reperfusion injury in perfused rabbit heart

By Yue T.-L.   Ma X.-L.   Gu J.-L.   Ruffolo R.R.   Feuerstein G.Z.  

European Journal of Pharmacology, Vol. 345, Iss. 1, 1998-03 ,pp. : 61-65

Elsevier

Access to resources Recommend Favorite

Activation of AMP-activated protein kinase (AMPK) inhibits protein synthesis: a potential strategy to prevent the development of cardiac hypertrophy

By Chan Anita Y.M   Dyck Jason R.B  

Canadian Journal of Physiology and Pharmacology, Vol. 83, Iss. 1, 2005-01 ,pp. : 24-28

NRC Research Press

Access to resources Recommend Favorite

Targeting protein kinase B/Akt signaling with vanadium compounds for cardioprotection

By Bhuiyan Md. Shenuarin   Shioda Norifumi   Fukunaga Kohji  

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 10, 2008-10 ,pp. : 1217-1227

Informa Healthcare

Access to resources Recommend Favorite